• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IL-22Ra1 is induced during influenza infection by direct and indirect TLR3 induction of STAT1

tetano

Editor, Senior Moderator
Respir Res. 2019 Aug 15;20(1):184. doi: 10.1186/s12931-019-1153-4.
[h=1]IL-22Ra1 is induced during influenza infection by direct and indirect TLR3 induction of STAT1.[/h] Hebert KD[SUP]1[/SUP], Mclaughlin N[SUP]1[/SUP], Zhang Z[SUP]1[/SUP], Cipriani A[SUP]2[/SUP], Alcorn JF[SUP]2[/SUP], Pociask DA[SUP]3[/SUP].
[h=3]Author information[/h] 1 Department of Medicine, Pulmonary Diseases, Critical Care & Environmental Medicine, Tulane University School of Medicine, 1430 Tulane Ave. Mail code sl279, New Orleans, LA, 70112, USA. 2 Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, One Children's Hospital Drive, 4401 Penn Ave, Pittsburgh, PA, 15224, USA. 3 Department of Medicine, Pulmonary Diseases, Critical Care & Environmental Medicine, Tulane University School of Medicine, 1430 Tulane Ave. Mail code sl279, New Orleans, LA, 70112, USA. dpociask@tulane.edu.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza attacks the epithelium of the lung, causing cell death and disruption of the epithelial barrier leading to fluid buildup in the lung and impairment of gas exchange. Limited treatment options for severe influenza pneumonia prioritize the need for the discovery of effective therapies. IL-22 is a cytokine that promotes tissue integrity and has strong promise as a treatment option. While research has been focused on the cytokine itself, there is limited understanding of the regulation of the IL-22 receptor (IL-22Ra1) at the epithelial surface during infection.
[h=4]METHODS:[/h] IL-22Ra1 levels were measured by qRT-PCR, western blot and immunofluorescence following H1N1 influenza infection (A/PR/8/34 H1N1) or synthetic TLR3 mimetic, Poly (I:C). Regulation of the receptor was determined using STAT inhibitors (STAT1, STAT3 and PanSTAT inhibitors), TLR3 inhibition, and neutralization of interferon alpha receptor 2 (IFNAR2). Significance was determined by a p-value of greater than 0.05. Significance between two groups was measured using unpaired t-test and significance between more than two groups was measured using one-way ANOVA with Tukey Multiple Comparison Test.
[h=4]RESULTS:[/h] Here we show both in vivo and in vitro that IL-22Ra1 was induced as early as 24 h after influenza (H1N1 PR8) infection. This induction was triggered by toll-like receptor 3 (TLR3) as a TLR3 mimetic [Poly (I:C)] also induced IL-22Ra1 and inhibition of endosomal formation required for TLR3 function inhibited this process. This upregulation was dependent upon IFNβ signaling through STAT1. Importantly, induction of IL-22Ra1 significantly increased IL-22 signaling as evidenced by pSTAT3 levels following IL-22 treatment.
[h=4]CONCLUSION:[/h] Collectively, these data suggest epithelial cells may optimize the beneficial effects of IL-22 through the induction of the IL-22 receptor during viral infection in the lung.


[h=4]KEYWORDS:[/h] IFNβ; IL-22; IL-22Ra1; Influenza; STAT1; TLR3

PMID: 31416461 PMCID: PMC6694528 DOI: 10.1186/s12931-019-1153-4
Free PMC Article
 
Back
Top Bottom